Literature DB >> 3783904

Partial muscle carnitine palmitoyltransferase-A deficiency. Rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy.

N S Ross, C L Hoppel.   

Abstract

After initiation of ibuprofen therapy, a 45-year-old woman developed muscle weakness and tenderness with rhabdomyolysis, culminating in respiratory failure. A muscle biopsy specimen showed a vacuolar myopathy, and markedly decreased muscle carnitine content and carnitine palmitoyltransferase activity. Following recovery, muscle carnitine content was normal but carnitine palmitoyltransferase activity was still abnormally low. The ratio of palmitoyl-coenzyme A plus carnitine to palmitoylcarnitine oxidation by muscle mitochondria isolated from the patient was markedly decreased. We conclude that transiently decreased muscle carnitine content interacted with partial deficiency of carnitine palmitoyltransferase-A to produce rhabdomyolysis and respiratory failure and that ibuprofen may have precipitated the clinical event.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3783904     DOI: 10.1001/jama.257.1.62

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

Review 1.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

2.  Extreme Elevation of Creatine Kinase in a Young Male Patient With Recurrent Rhabdomyolysis.

Authors:  Layla Al Bizri; Anh Do; Daniel R Ouellette
Journal:  Cureus       Date:  2022-05-07

3.  Homozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouse.

Authors:  Shaonin Ji; Yun You; Janos Kerner; Charles L Hoppel; Trenton R Schoeb; Wallace S H Chick; Doug A Hamm; J Daniel Sharer; Philip A Wood
Journal:  Mol Genet Metab       Date:  2007-11-19       Impact factor: 4.797

Review 4.  Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: A case report and systematic review of the literature.

Authors:  Nicholas Ivin; Valentina Della Torre; Francis Sanders; Matthew Youngman
Journal:  J Intensive Care Soc       Date:  2019-12-18

5.  Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency.

Authors:  S Zierz; R R Mundegar; F Jerusalem
Journal:  Clin Investig       Date:  1993-12

Review 6.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.